Analytical validation of human epidermal growth factor receptor 2 immunohistochemistry by the use of the A0485 antibody versus the 4B5 antibody and breast versus gastric scoring guidelines in ovarian clear cell carcinoma-Reference-Cited by-同舟云学术

Analytical validation of human epidermal growth factor receptor 2 immunohistochemistry by the use of the A0485 antibody versus the 4B5 antibody and breast versus gastric scoring guidelines in ovarian clear cell carcinoma

Published:2021-08-06 Issue:5 Volume:79 Page:758-767
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Lin Shih‐Yao¹^ORCID,Wang Yeh‐Han²³⁴,Hsu Chih‐Yi¹³⁵^ORCID,Chen Yi‐Jen⁶⁷,Lai Chiung‐Ru¹⁵,Hang Jen‐Fan¹⁵^ORCID

Affiliation:

1. Department of Pathology and Laboratory Medicine Taipei Veterans General Hospital TaipeiTaiwan

2. Department of Pathology Heping Fuyou Branch Taipei City Hospital TaipeiTaiwan

3. College of Nursing National Taipei University of Nursing and Health Sciences TaipeiTaiwan

4. Institute of Public Health National Yang Ming Chiao Tung University TaipeiTaiwan

5. School of Medicine National Yang Ming Chiao Tung University TaipeiTaiwan

6. Department of Obstetrics and Gynaecology Taipei Veterans General Hospital TaipeiTaiwan

7. Institute of Clinical Medicine National Yang Ming Chiao Tung University Taipei Taiwan

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.14419

Reference39 articles.

1. Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO–JSOG joint study

2. Prognostic factors in epithelial ovarian cancer: A population-based study

3. Cystic and Adenofibromatous Clear Cell Carcinomas of the Ovary

4. Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exceptional Response to Trastuzumab Deruxtecan in a Patient With Recurrent Ovarian Clear Cell Carcinoma With Human Epidermal Growth Factor Receptor 2 Expression;JCO Precision Oncology;2024-06

2. HER-2 overexpression in female genital tract clear cell carcinomas: Evaluation of different scoring guidelines, clinicopathological features and prognostic impact;Annals of Diagnostic Pathology;2023-10

3. HER2 Expression in Peritoneal Dissemination of High-Grade Serous Ovarian Carcinoma: A Comparative Study of Immunohistochemical Reactivity Using Four HER2 Antibodies;Journal of Clinical Medicine;2022-11-25